Navigation Links
Lauren Marangell, M.D. to Join Lilly; Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar
Date:9/21/2007

INDIANAPOLIS, Sept. 21 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today announced that Lauren Marangell, M.D., will join Lilly in November 2007, as a Distinguished Lilly Scholar focusing on depression and related disorders.

"We are delighted to recruit someone with Dr. Marangell's stature and depth of experience to join Lilly," said Jack Harris, M.D., vice president, U.S. medical division. "Lauren brings a national and international reputation in depression and other mood disorders. This experience will allow her to play a key scientific leadership role in our relationships with the U.S. healthcare community and the broader clinical and scientific community, providing quality information regarding Lilly products and research."

Marangell joins Lilly from Baylor College of Medicine where she is Brown Foundation Chair in psychopharmacology of mood disorders, professor of psychiatry with tenure and director of mood disorders research. At Baylor, she developed a state-of-the-art mood disorders research program recognized as one of the most successful in the country. She has held numerous national and international leadership positions and is a scientific reviewer for most major journals in the field. In addition to her success in research, Marangell is well known as a prominent clinician and educator. Among many awards of note, she is a recipient of the "Exemplary Psychiatrist Award" from the National Alliance for the Mentally Ill, and is listed in "Who's Who Among American Educators." She is first author of the "Concise Guide to Psychopharmacology", with coauthor James Martinez, M.D., now also with Lilly.

"I am very excited that Lauren chose to join Lilly," said John Hayes, M.D., vice president, global brand development platform leader - neuroscience. "She is a world-class physician who will provide significant understanding of the external environment and key insights to Lilly's drug development programs. She is an outstanding addition to Lilly's research team."

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com.

C-LLY

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Thailand To Procure Botulism Antitoxin Internationally
2. Time magazine has recognized efforts of two Indian doctors towards reducing infant mortality rate
3. Nurse Practitioners Are Not Recognized By Medicare
4. Scientist Recognized for Drug Addiction Research
5. Medical Center Recognized for Excellence in Bariatric Surgery
6. A young scientist recognized for biomechanics innovations
7. Distinguishable Traits of Fatal Skin Cancer Recognized
8. Bipolar Spectrum Disorder may Be Under-recognized for Spectrum Disorder: Study
9. Smoking a greater risk than HIV? Yes say health experts!!!!
10. Roche offers HIV drug expertise to poor nations
11. Good carb, bad carb? Experts debate.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2016)... (PRWEB) , ... May 01, 2016 , ... Outdoor Growing ... medical marijuana industry, has put the law in the hands of the local ... January 1, 2016, California voted to allow counties to vote on growing regulations by ...
(Date:4/30/2016)... Marne, Michigan (PRWEB) , ... May 01, 2016 , ... ... holistic approach to rehabilitation, has produced a new video that focuses on one of ... of their recent sessions and clips from interviews with a participating patients and the ...
(Date:4/30/2016)... ... April 30, 2016 , ... Powerful tools of ... Mary O'Maley. What is hypnosis and hypnotherapy and why after centuries, it ... pain relief (chronic and acute), birthing processes and medical procedures, depression, anxiety, fear ...
(Date:4/30/2016)... Austin, Texas (PRWEB) , ... April 30, 2016 ... ... time to celebrate the profession and recognize veterinarians’ global impact on public health. ... choose a theme each year, and this year have selected continuing education with ...
(Date:4/30/2016)... ... April 30, 2016 , ... ... 4th, 2016 questioned the use of the HyProCure sinus tarsi implant. ( ... procedure.” EOTTS-HyProCure is a minimally invasive procedure performed, when indicated, to correct ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... , April 29, 2016  In the ... projected to shift from systems dependent on CRTs monitors ... types of modality CRT Medical monitors and will ... are a host of foreseeable benefits to this ... will existing modalities have to be replaced in ...
(Date:4/29/2016)... ReportsnReports.com adds "Pulmonary Arterial ... report that provides an overview of the PAH ... stages, therapeutics assessment by drug target, mechanism of ... type, along with latest updates, and featured news ... involved in the therapeutic development for Pulmonary Arterial ...
(Date:4/29/2016)... April 29, 2016 Acquisition ... Sciences, Product Development Capabilities in North ... Base . Indegene ( http://www.indegene.com ... the acquisition of Skura Corporation,s life science business. ... adaptive sales enablement technology for life science organizations ...
Breaking Medicine Technology: